Antituberculosis Toxicity
Hepatotoxicity self-limiting after short-course therapy for latent tuberculosis
Published in TB and Outbreaks Week, August 29th, 2006
"Nine months of isoniazid therapy is the recommended regimen for treatment of latent tuberculosis infection, but low completion rates are a serious problem. The search for shorter regimens, compared with the standard isoniazid regimen, is of vital importance.
"We describe our experience using short-course regimens for the treatment of latent tuberculosis infection. We conducted a nonrandomized, observational study of 459 patients in a county health department from June 2000 to January 2006," researchers in the United States report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Avian Influenza
Avian influenza virus A/chicken/Yamaguchi/7/04 (H5N1) strain highly pathogenic to other birds - Norovirus Outbreaks
Noroviruses are an important cause of gastroenteritis in Taiwan - Tuberculosis Epidemiology
Tuberculosis infectiousness of initial case associated with higher rate of cluster growth - Antimicrobials
Bisbenzamidine derivatives active against Pneumocystis pneumonia and less toxic than pentamidine - Aspergillus Endophthalmitis Treatment
Intravitreal voriconazole successfully treats Aspergillus endophthalmitis infection - Avian Influenza
New bird flu drug promises to beat the problem of resistance - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
